Background Despite the goal set by WHO to eliminate hepatitis C virus (HCV) as a public
health threat, uptake of HCV testing and treatment remains low. To achieve this target …

Introduction. Direct-acting antiviral medications have made hepatitis C virus (HCV) cure
possible for> 95% of persons with chronic HCV infection, including those coinfected with …

Loss of follow-up or reinfections hinder the expectations of hepatitis C eradication despite
the existence of highly effective treatments. Moreover, the elimination of the infection does …

Introduction. Universal one-time screening for hepatitis C virus (HCV) is recommended for
all adults. For persons with HIV (PWH), guidelines recommend HCV screening at entry into …

Abstract Background and Aim Direct‐acting antivirals (DAAs) have recently been developed
to treat hepatitis C virus (HCV) infection. Additionally, interferon‐free DAA treatment has …

Abstract Background and Aims The path to hepatitis C virus (HCV) elimination is
complicated by individuals who become lost to follow‐up (LTFU) during care, particularly …

(1) Background: Low rates of hepatitis C virus (HCV) diagnosis and sub-optimal linkage to
care constitute barriers toward eliminating the infection. In 2012/2013, we showed that HCV …

Background: Historically, hepatitis C virus (HCV) pretreatment evaluation has required
multiple visits, frequently resulting in loss to follow-up and a delayed initiation of treatment …

Hepatitis C is the most infectious bloodborne disease in the United States. For my
dissertation, I will focus on the study population in Orange County, California. This high-risk …

Background Residents lack exposure to chronic hepatitis C (HCV) infection management,
limiting the pipeline of providers able to alleviate the treatment bottleneck. Activity We …